China Biologic Products, Inc. (CBPO.OB) Appoints Director of Research and Development
China Biologic Products, Inc. has been gaining a reputation as one of the leading plasma-based pharmaceutical companies in the People’s Republic of China and has obtained great success operating through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co. and Chongging Dalin Biologic Technologies Co. While the young company has been making strides across the globe, they obtained a major asset to their company with the announcement that they have appointed Dr. Vincent Yi-Wu Xie to become the new Director of Research and Development. Dr. Xie brings a lot of experience and credibility to the China Biologic team. Dr. Xie…